Apomorphine and levodopa challenge in patients with a focal midbrain lesion

Elena Moro, Alberto Albanese

Research output: Contribution to journalArticle

Abstract

Three patients who presented with parkinsonian signs resulting from a focal midbrain lesion are reported. In all patients parkinsonian features occurred acutely and improved following acute challenge with apomorphine but not with levodopa. Remission of parkinsonian signs occurred spontaneously to a different degree. Inconsistent clinical response following administration of levodopa has been well documented in patients with focal midbrain lesions associated with parkinsonian signs; however, the efficacy of apomorphine has not been tested before. Anatomic or etiologic features do not allow us to predict in which cases parkinsonian signs secondary to a midbrain lesion would respond to levodopa or to dopamine agonists. A trial with apomorphine is warranted in all such cases.

Original languageEnglish
Pages (from-to)269-275
Number of pages7
JournalMovement Disorders
Volume14
Issue number2
DOIs
Publication statusPublished - 1999

Fingerprint

Apomorphine
Levodopa
Mesencephalon
Dopamine Agonists

Keywords

  • Apomorphine
  • Levodopa
  • Mesencephalon
  • Movement disorders
  • Parkinson's disease
  • Secondary parkinsonism

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)

Cite this

Apomorphine and levodopa challenge in patients with a focal midbrain lesion. / Moro, Elena; Albanese, Alberto.

In: Movement Disorders, Vol. 14, No. 2, 1999, p. 269-275.

Research output: Contribution to journalArticle

@article{b6f2a966e0c94bf5822ad09fb02d6277,
title = "Apomorphine and levodopa challenge in patients with a focal midbrain lesion",
abstract = "Three patients who presented with parkinsonian signs resulting from a focal midbrain lesion are reported. In all patients parkinsonian features occurred acutely and improved following acute challenge with apomorphine but not with levodopa. Remission of parkinsonian signs occurred spontaneously to a different degree. Inconsistent clinical response following administration of levodopa has been well documented in patients with focal midbrain lesions associated with parkinsonian signs; however, the efficacy of apomorphine has not been tested before. Anatomic or etiologic features do not allow us to predict in which cases parkinsonian signs secondary to a midbrain lesion would respond to levodopa or to dopamine agonists. A trial with apomorphine is warranted in all such cases.",
keywords = "Apomorphine, Levodopa, Mesencephalon, Movement disorders, Parkinson's disease, Secondary parkinsonism",
author = "Elena Moro and Alberto Albanese",
year = "1999",
doi = "10.1002/1531-8257(199903)14:2<269::AID-MDS1012>3.0.CO;2-X",
language = "English",
volume = "14",
pages = "269--275",
journal = "Movement Disorders",
issn = "0885-3185",
publisher = "John Wiley and Sons Inc.",
number = "2",

}

TY - JOUR

T1 - Apomorphine and levodopa challenge in patients with a focal midbrain lesion

AU - Moro, Elena

AU - Albanese, Alberto

PY - 1999

Y1 - 1999

N2 - Three patients who presented with parkinsonian signs resulting from a focal midbrain lesion are reported. In all patients parkinsonian features occurred acutely and improved following acute challenge with apomorphine but not with levodopa. Remission of parkinsonian signs occurred spontaneously to a different degree. Inconsistent clinical response following administration of levodopa has been well documented in patients with focal midbrain lesions associated with parkinsonian signs; however, the efficacy of apomorphine has not been tested before. Anatomic or etiologic features do not allow us to predict in which cases parkinsonian signs secondary to a midbrain lesion would respond to levodopa or to dopamine agonists. A trial with apomorphine is warranted in all such cases.

AB - Three patients who presented with parkinsonian signs resulting from a focal midbrain lesion are reported. In all patients parkinsonian features occurred acutely and improved following acute challenge with apomorphine but not with levodopa. Remission of parkinsonian signs occurred spontaneously to a different degree. Inconsistent clinical response following administration of levodopa has been well documented in patients with focal midbrain lesions associated with parkinsonian signs; however, the efficacy of apomorphine has not been tested before. Anatomic or etiologic features do not allow us to predict in which cases parkinsonian signs secondary to a midbrain lesion would respond to levodopa or to dopamine agonists. A trial with apomorphine is warranted in all such cases.

KW - Apomorphine

KW - Levodopa

KW - Mesencephalon

KW - Movement disorders

KW - Parkinson's disease

KW - Secondary parkinsonism

UR - http://www.scopus.com/inward/record.url?scp=0033430126&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033430126&partnerID=8YFLogxK

U2 - 10.1002/1531-8257(199903)14:2<269::AID-MDS1012>3.0.CO;2-X

DO - 10.1002/1531-8257(199903)14:2<269::AID-MDS1012>3.0.CO;2-X

M3 - Article

C2 - 10091621

AN - SCOPUS:0033430126

VL - 14

SP - 269

EP - 275

JO - Movement Disorders

JF - Movement Disorders

SN - 0885-3185

IS - 2

ER -